# Gentamicin in Preventing Post Endoscopic Retrograde Cholangiopancreatography (ERCP) Cholangitis in Non-calculus Stenting

> **NCT01148693** · NA · COMPLETED · sponsor: **Tehran University of Medical Sciences** · enrollment: 114 (actual)

## Conditions studied

- Cholangitis

## Interventions

- **DRUG:** gentamicin
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01148693
- **Lead sponsor:** Tehran University of Medical Sciences
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-12
- **Primary completion:** 2010-12
- **Final completion:** 2010-12
- **Target enrollment:** 114 (ACTUAL)
- **Last updated:** 2011-09-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01148693

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01148693, "Gentamicin in Preventing Post Endoscopic Retrograde Cholangiopancreatography (ERCP) Cholangitis in Non-calculus Stenting". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT01148693. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*